These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 3334565

  • 1. Alterations of pharmacokinetic characteristics of antibiotics during sepsis: experimental and clinical data.
    Ganzinger U, Kleinberger G, Lenz K, Grimm G, Laggner A, Haslberger A, Schatz F, Millendorfer A, Martindale JJ.
    Chemioterapia; 1987 Jun; 6(2 Suppl):246-8. PubMed ID: 3334565
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.
    McKinnon PS, Paladino JA, Schentag JJ.
    Int J Antimicrob Agents; 2008 Apr; 31(4):345-51. PubMed ID: 18313273
    [Abstract] [Full Text] [Related]

  • 3. Cefepime versus ceftazidime: considerations for empirical use in critically ill patients.
    Roberts JA, Webb SA, Lipman J.
    Int J Antimicrob Agents; 2007 Feb; 29(2):117-28. PubMed ID: 17158033
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative study of the disposition of levofloxacin, netilmicin and cefepime in the isolated rat lung.
    Martínez Martínez MS, Gandarillas CI, Martínez Lanao J, Sánchez Navarro A.
    J Pharm Pharmacol; 2005 Jul; 57(7):861-7. PubMed ID: 15969945
    [Abstract] [Full Text] [Related]

  • 6. Simulation of human pharmacokinetic profiles in mice, and impact on antimicrobial efficacy of netilmicin, ticarcillin and ceftazidime in the peritonitis-septicemia model.
    Gerber AU, Stritzko T, Segessenmann C, Stalder B.
    Scand J Infect Dis Suppl; 1990 Jul; 74():195-203. PubMed ID: 2151488
    [Abstract] [Full Text] [Related]

  • 7. Can bioimpedance determine the volume of distribution of antibiotics in sepsis?
    Balik M, Sedivy J, Waldauf P, Kolar M, Smejkalova V, Pachl J.
    Anaesth Intensive Care; 2005 Jun; 33(3):345-50. PubMed ID: 15973917
    [Abstract] [Full Text] [Related]

  • 8. Antibiotic use in neonatal sepsis.
    Yurdakök M.
    Turk J Pediatr; 1998 Jun; 40(1):17-33. PubMed ID: 9722468
    [Abstract] [Full Text] [Related]

  • 9. Combined cephalosporin aminoglycoside therapy in gram-negative sepsis. The choice of cephalosporin.
    Mészáros J, Tołłoczko T, Stachlewska E, Tyc Z, Jeljaszewicz J.
    J Chemother; 1989 Jul; 1(4 Suppl):828-9. PubMed ID: 16312658
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J, Dofferhoff AS, Mouton JW, van der Meer JW.
    J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
    [Abstract] [Full Text] [Related]

  • 13. Single-dose and short-course netilmicin prophylaxis in urologic surgery: pharmacokinetic and clinical evaluation.
    Graber H, Kondás J, Magyar T, Csiba A, Arr A.
    J Chemother; 1989 Jul; 1(4 Suppl):1018-9. PubMed ID: 16312752
    [No Abstract] [Full Text] [Related]

  • 14. Individualising netilmicin dosing in neonates.
    Sherwin CM, Broadbent RS, Medlicott NJ, Reith DM.
    Eur J Clin Pharmacol; 2008 Dec; 64(12):1201-8. PubMed ID: 18685839
    [Abstract] [Full Text] [Related]

  • 15. An overview of the newer antibiotics.
    del Busto R.
    Henry Ford Hosp Med J; 1984 Dec; 32(2):90-8. PubMed ID: 6392210
    [No Abstract] [Full Text] [Related]

  • 16. [Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage].
    Cazzola M, Noschese P, Vinciguerra A, Di Perna F, Califano C, Berra A.
    Minerva Med; 1998 Dec; 89(1-2):15-22. PubMed ID: 9561021
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic disposition and bioavailability of cefepime in buffalo calves.
    Joshi B, Sharma SK.
    J Vet Pharmacol Ther; 2007 Oct; 30(5):500-2. PubMed ID: 17803748
    [No Abstract] [Full Text] [Related]

  • 18. Lipopolyamines as a therapeutic strategy in experimental Gram-negative bacterial sepsis.
    Opal SM, Palardy JE, Parejo N, Morrison DC.
    J Endotoxin Res; 2001 Oct; 7(1):35-8. PubMed ID: 11521079
    [Abstract] [Full Text] [Related]

  • 19. Netilmicin in the neonate: pharmacokinetic analysis and influence of parenteral nutrition.
    Bacopoulou F, Skouroliakou M, Markantonis SL.
    Pharm World Sci; 2009 Jun; 31(3):365-8. PubMed ID: 19169898
    [Abstract] [Full Text] [Related]

  • 20. Sputum and serum pharmacokinetics of loracarbef (LY163892) in patients with bronchial sepsis.
    Connell C, Aspinall S, Corkill J.
    J Antimicrob Chemother; 1995 Aug; 36(2):446-7. PubMed ID: 8522479
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.